AtriCure (ATRC) Reports Q4 Loss, Lags Revenue Estimates

AtriCure (ATRC) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 46.67%. A quarter ago, it was expected that this medical device maker would post a loss of $0.20 per share when it actually produced a loss of $0.17, delivering a surprise of 15%.Over the last four quarters, the company has surpa ...